Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals of Thoracic Surgery

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ATHORACSUR.2005.05.088PMID 16181847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?

  2005cited by this paper
• Detection of Lymph Node Micrometastases by Gene Promoter Hypermethylation in Samples Obtained by Endosonography- Guided Fine-Needle Aspiration Biopsy

  2004cited by this paper
• Promoter Hypermethylation of Resected Bronchial Margins

  2004cited by this paper
• GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer

  2003cited by this paper
• Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.

  2003cited by this paper
• Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.

  2003cited by this paper
• Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

  2003cited by this paper
• Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

  2002cited by this paper
• Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer

  2002cited by this paper
• Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.

  2002cited by this paper
• K-ras mutations and RASSF1A promoter methylation in colorectal cancer

  2002cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Management of malignant pleural effusions.

  2001cited by this paper
• SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise.

  2000cited by this paper
• Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.

  2000cited by this paper
• Promoter-region hypermethylation and gene silencing in human cancer.

  2000cited by this paper
• Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

  2000cited by this paper
• Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.

  2000cited by this paper
• Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.

  1999cited by this paper
• Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions

  1999cited by this paper
• Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

  1999cited by this paper
• p16(INK4): involvement early and often in gastrointestinal malignancies.

  1999cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• The safety and versatility of video-thoracoscopy: a prospective analysis of 895 consecutive cases.

  1996cited by this paper
• Diagnosis and management of malignant pleural effusions.

  1995cited by this paper
• Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.

  1995cited by this paper
• Thoracoscopy: present diagnostic and therapeutic indications.

  1993cited by this paper
• Thoracoscopy for the diagnosis of pleural disease.

  1991cited by this paper
• Ca 72‐4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers

  1990cited by this paper
• Survival of patients with malignancy-associated effusions.

  1989cited by this paper
• Survival of patients with malignancy-associated effusions.

  1989cited by this paper
• Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.

  1988cited by this paper
• Pleural effusions.

  1986cited by this paper
• Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease

  1983cited by this paper
• Thoracoscopy in malignant pleural effusions.

  1981cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper
• Carcinomatous involvement of the pleura: an analysis of 96 patients.

  1977cited by this paper

• Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score

  2022cites this paper
• Pleural diseases related to unknown primary carcinoma—a multidisciplinary approach in diagnosis and treatment

  2020cites this paper
• The International System for Serous Fluid Cytopathology

  2020cites this paper
• Ancillary Studies for Serous Fluids

  2020cites this paper
• Malignant pleural effusion and cancer of unknown primary site: a review of literature.

  2019cites this paper
• Pleurésies tumorales : diagnostic et principes de prise en charge

  2019cites this paper
• A 2‐year retrospective study on pleural effusions: A cancer centre experience

  2019cites this paper
• Pleural Effusions in Lung Cancer: Detection and Treatment

  2018cites this paper
• Evaluation of photoshop based image analysis in cytologic diagnosis of pleural fluid in comparison with conventional modalities

  2018cites this paper
• Diagnostic and Prognostic Value of Survivin in Pleural Effusion

  2018cites this paper
• Medical thoracoscopy for exudative pleural effusion: an eight-year experience from a country with a young population

  2017cites this paper
• A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non–Small Cell Lung Cancer and Serum DNA

  2017cites this paper
• 82 – Pleural Tumors

  2016cites this paper
• Review: Cell Dynamics in Malignant Pleural Effusions

  2015cites this paper
• Epstein-Barr virus-positive pleural effusion: Clinical features, cytomorphologic characteristics, and flow cytometric immunophenotyping.

  2014cites this paper
• Body cavity fluids.

  2014cites this paper
• Value of F-18-FDG PET/CT for determining malignant pleural effusion in patients with cancer

  2014cites this paper
• Diagnostic Value of p16 Methylation for Malignant Pleural Effusions: A Meta-analysis.

  2014cites this paper
• Rare pleural tumors.

  2013cites this paper
• Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions

  2013influential citation
• Malignant pleural effusion and algorithm management.

  2013cites this paper
• SHOX2 DNA methylation is a tumour marker in pleural effusions.

  2013cites this paper
• 18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer

  2012cites this paper
• Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma

  2012cites this paper
• Diagnostic molecular biomarkers for malignant pleural effusions.

  2011cites this paper
• Tumeurs secondaires de la plèvre Diagnostic, traitement local

  2011cites this paper
• Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.

  2011cites this paper
• Etude multicentrique de nouveaux marqueurs tumoraux moléculaires dans les épanchements péritonéaux et le sang : analyse par PCR quantitative en temps réel

  2010cites this paper
• Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression

  2010cites this paper
• Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.

  2010cites this paper
• The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

  2010cites this paper
• Pleurésies néoplasiques : diagnostic et principes de prise en charge

  2010cites this paper
• Tumors of the Pleura

  2010cites this paper
• Utility of Promoter Hypermethylation for Differentiating Malignant and Benign Effusions in Liquid-Based Cytology Specimens

  2010influential citation
• DNA methylation as a biomarker in breast cancer.

  2009cites this paper
• Diagnosis and staging of lung and pleural malignancy - an overview of tissue sampling techniques and the implications for pathological assessment.

  2009cites this paper
• WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions

  2009cites this paper
• The Role of Positron Emission Tomography/Computed Tomography in the Diagnosis of Pleural Diseases

  2009cites this paper
• Nuevas técnicas de imagen en el derrame pleural

  2009cites this paper
• Tumors of the Pleura and Mediastinum

  2008cites this paper
• Differentiation Between Malignant and Benign Pleural Effusions: Methylation Specific Polymerase Chain Reaction Analysis

  2008cites this paper
• Recent advances in the diagnosis and management of malignant pleural effusions.

  2008cites this paper
• Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

  2007cites this paper
• Diagnosis and management of malignant pleural effusions

  2007cites this paper
• Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion

  2006influential citation